NCT04273139 2025-07-30Ibrutinib + Venetoclax in Untreated WMDana-Farber Cancer InstitutePhase 2 Active not recruiting45 enrolled 15 charts
NCT02677324 2022-05-11Study of ABT-199 (GDC-199) In Patients With Relapsed Or Refractory Waldenström MacroglobulinemiaDana-Farber Cancer InstitutePhase 2 Completed33 enrolled 15 charts